Validation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy Exposure.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/10329

Title:	Validation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy Exposure.
Authors:	Gonzalez-Serna, A Genebat, M De Luna-Romero, M Tarancon-Diez, L Dominguez-Molina, B Pacheco, Y M Muñoz-Fernández, M A Leal, M Ruiz-Mateos, E
metadata.dc.subject.mesh:	Cyclohexanes HIV HIV Fusion Inhibitors Humans Inhibitory Concentration 50 Maraviroc Triazoles Viral Tropism Virology
Issue Date:	23-Sep-2016
Abstract:	TROCAI is a phenotypic tropism test developed using the virological response to a short-term exposure to maraviroc monotherapy (Maraviroc Clinical Test [MCT]). It was found that with TROCAI, a cutoff of
URI:	http://hdl.handle.net/10668/10329
metadata.dc.identifier.doi:	10.1128/AAC.01326-16
Appears in Collections:	Instituto de Investigación Biomédica de Sevilla (IBIS) SAS - Hospital Universitario Virgen del Rocío

Files in This Item:

There are no files associated with this item.

This item is protected by original copyright

Show full item record Recommend this item

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.

RISalud